A role for Fli-1 in B cell proliferation: implications for SLE pathogenesis.

Area of Science:

• Immunology
• Molecular Biology
• Pathogenesis of Autoimmune Diseases

Background:

• Fli-1 overexpression is linked to systemic lupus erythematosus (SLE)-like disease in mice and humans.
• Reducing Fli-1 expression ameliorates SLE-like symptoms in MRL/lpr mice, including reduced autoantibodies and renal pathology.

Purpose of the Study:

• To investigate the role of Fli-1 in B cell proliferation and its potential contribution to SLE pathogenesis.
• To determine if Fli-1 deficiency impacts B cell receptor (BCR) and Toll-like receptor (TLR) expression.
• To identify molecular mediators affected by Fli-1 deficiency in B cells.

Main Methods:

• Comparative analysis of B cell proliferation in Fli-1-deficient and wild-type mice (both lupus-prone and control).
• Assessment of mitogen receptor expression (BCR, TLR4, TLR9) on naïve B cells.
• Quantitative analysis of IL12a and NFAT transcript levels in Fli-1-deficient MRL/lpr B cells.

Main Results:

• Fli-1-deficient naïve B cells exhibited reduced proliferative responses to mitogens.
• Expression levels of BCR, TLR4, and TLR9 were not significantly altered in Fli-1-deficient B cells.
• Fli-1 deficiency in MRL/lpr B cells led to upregulated IL12a and downregulated NFAT transcripts.

Conclusions:

• Fli-1 deficiency impairs B cell proliferative responses to mitogens, independent of BCR and TLR expression.
• Upregulation of IL12a and downregulation of NFAT are potential mechanisms mediating the effect of Fli-1 on B cell function.
• These findings suggest a role for Fli-1 in B cell hyperactivity and SLE pathogenesis.